Phase II study of first-line LY231514 (multi-targeted antifolate) in patients with locally advanced or metastatic colorectal cancer: An NCIC Clinical Trials Group study
Autor: | Cripps, C. *, Burnell, M., Jolivet, J., Batist, G., Lofters, W., Dancey, J., Iglesias, J., Fisher, B., Eisenhauer, E.A. |
---|---|
Zdroj: | In Annals of Oncology October 1999 10(10):1175-1179 |
Databáze: | ScienceDirect |
Externí odkaz: |